Please assess the completion status of the following clinical trial:

Trial Title: Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient age ≥18 years;~2. From onset to treatment ≤ 48 hours;~3. Ischemic stroke confirmed by head CT or MRI;~4. 6≤NIHSS score ≤ 16;~5. Premorbid mRS ≤ 1;~6. Signed informed consent.~Exclusion Criteria:~1. Serious neurological deficits before onset ( mRS ≥ 2)；~2. The aetiology of cardiogenic embolism, such as rheumatic mitral or aortic stenosis, artificial heart valve, atrial fibrillation, atrial flutter, sick sinus syndrome, left atrial myxoma, left ventricular wall thrombus or valve neoplasm, congestive heart failure, bacterial endocarditis, etc;~3. Uncontrolled severe hypertension (Systolic pressure ≥180 mmHg or diastolic pressure ≥110 mmHg after drug treatment);~4. Subclavian artery stenosis ≥ 50% or subclavian steal syndrome;~5. Intracranial tumor, arteriovenous malformation or aneurysm;~6. Severe abnormalities in coagulation;~7. Any contraindication for remote ischemic adaptation: the upper limb has serious soft tissue injury, fracture or vascular injury, distal upper limb perivascular lesions, etc.;~8. Comorbidity with any serious diseases and life expectancy is less than half a year;~9. Participating in other clinical trials within 3 months;~10. Patients not suitable for this clinical studies considered by researcher;

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Guideline-based therapy+RIC (Type: EXPERIMENTAL): RIC is given twice a day with 200mmHg pressure.
- Guideline-based therapy (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).